$AWH
Aspira Women's Health Inc.

2019 Q1 Form 10-K Financial Statement

#000092661719000007 Filed on March 28, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 2017 Q4
Revenue $803.0K $3.053M $800.0K
YoY Change 23.73% -2.18% -1.23%
Cost Of Revenue $694.0K $3.142M $710.0K
YoY Change -13.57% 7.82% -7.79%
Gross Profit $109.0K -$89.00K $80.00K
YoY Change -170.78% -143.0% 100.0%
Gross Profit Margin 13.57% -2.92% 10.0%
Selling, General & Admin $3.619M $10.69M $2.870M
YoY Change 42.54% 9.0% 11.67%
% of Gross Profit 3320.18% 3587.5%
Research & Development $209.0K $550.0K $150.0K
YoY Change 47.18% -34.29% -50.0%
% of Gross Profit 191.74% 187.5%
Depreciation & Amortization $124.0K $675.0K $190.0K
YoY Change -33.33% -14.12% -5.0%
% of Gross Profit 113.76% 237.5%
Operating Expenses $3.828M $11.24M $3.030M
YoY Change 42.78% 5.6% 5.57%
Operating Profit -$3.719M -$11.33M -$2.950M
YoY Change 31.18% 8.54% 4.24%
Interest Expense $10.00K -$20.00K -$10.00K
YoY Change -200.0% -50.0% 0.0%
% of Operating Profit
Other Income/Expense, Net -$4.000K -$16.00K -$10.00K
YoY Change 33.33% 14.29%
Pretax Income -$3.720M -$11.37M -$2.960M
YoY Change 30.53% 8.29% 3.86%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.716M -$11.37M -$2.960M
YoY Change 30.39% 8.33% 3.86%
Net Earnings / Revenue -462.76% -372.45% -370.0%
Basic Earnings Per Share -$0.16
Diluted Earnings Per Share -$49.26K -$0.16 -$49.29K
COMMON SHARES
Basic Shares Outstanding 75.53M 70.09M
Diluted Shares Outstanding 70.09M

Balance Sheet

Concept 2019 Q1 2018 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.200M $9.400M $5.500M
YoY Change 100.0% 70.91% 5.77%
Cash & Equivalents $6.174M $9.400M $5.539M
Short-Term Investments
Other Short-Term Assets $600.0K $600.0K $500.0K
YoY Change 20.0% 20.0% 0.0%
Inventory $98.00K $100.0K $102.0K
Prepaid Expenses
Receivables $699.0K $800.0K $205.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $7.576M $10.80M $6.305M
YoY Change 72.18% 71.43% 3.36%
LONG-TERM ASSETS
Property, Plant & Equipment $531.0K $600.0K $1.181M
YoY Change -46.9% -50.0% -37.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $147.0K $0.00 $11.00K
YoY Change
Total Long-Term Assets $678.0K $600.0K $1.192M
YoY Change -32.2% -50.0% -37.26%
TOTAL ASSETS
Total Short-Term Assets $7.576M $10.80M $6.305M
Total Long-Term Assets $678.0K $600.0K $1.192M
Total Assets $8.254M $11.40M $7.497M
YoY Change 52.85% 52.0% -6.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.157M $1.000M $745.0K
YoY Change 44.63% 42.86% -17.22%
Accrued Expenses $1.879M $1.800M $1.650M
YoY Change 4.39% 5.88% 10.0%
Deferred Revenue
YoY Change
Short-Term Debt $190.0K $200.0K $185.0K
YoY Change -5.0% 0.0% -7.5%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.336M $3.000M $2.609M
YoY Change 19.14% 15.38% 0.35%
LONG-TERM LIABILITIES
Long-Term Debt $1.244M $1.300M $1.481M
YoY Change -11.14% -13.33% -12.88%
Other Long-Term Liabilities $37.00K
YoY Change
Total Long-Term Liabilities $1.281M $1.300M $1.481M
YoY Change -8.5% -13.33% -12.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.336M $3.000M $2.609M
Total Long-Term Liabilities $1.281M $1.300M $1.481M
Total Liabilities $4.617M $4.300M $4.090M
YoY Change 9.93% 4.88% -4.88%
SHAREHOLDERS EQUITY
Retained Earnings -$410.6M -$396.1M
YoY Change
Common Stock $75.00K $60.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.637M $7.200M $3.407M
YoY Change
Total Liabilities & Shareholders Equity $8.254M $11.40M $7.497M
YoY Change 52.85% 52.0% -6.29%

Cashflow Statement

Concept 2019 Q1 2018 2017 Q4
OPERATING ACTIVITIES
Net Income -$3.716M -$11.37M -$2.960M
YoY Change 30.39% 8.33% 3.86%
Depreciation, Depletion And Amortization $124.0K $675.0K $190.0K
YoY Change -33.33% -14.12% -5.0%
Cash From Operating Activities -$3.108M -$9.367M -$2.150M
YoY Change 31.86% 15.23% -22.1%
INVESTING ACTIVITIES
Capital Expenditures $49.00K $113.0K $0.00
YoY Change 104.17% 88.33% -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$48.00K -$113.0K $0.00
YoY Change 100.0% 88.33% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $8.990M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -30.00K 13.30M -50.00K
YoY Change -45.45% 56.74% -16.67%
NET CHANGE
Cash From Operating Activities -3.108M -9.367M -2.150M
Cash From Investing Activities -48.00K -113.0K 0.000
Cash From Financing Activities -30.00K 13.30M -50.00K
Net Change In Cash -3.186M 3.821M -2.200M
YoY Change 30.79% 1186.53% -22.54%
FREE CASH FLOW
Cash From Operating Activities -$3.108M -$9.367M -$2.150M
Capital Expenditures $49.00K $113.0K $0.00
Free Cash Flow -$3.157M -$9.480M -$2.150M
YoY Change 32.59% 15.77% -21.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-12-31
CY2018 dei Document Type
DocumentType
10-K
CY2018 dei Entity Central Index Key
EntityCentralIndexKey
0000926617
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
75532748
CY2018 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2018Q2 dei Entity Public Float
EntityPublicFloat
33929264
CY2018 dei Entity Registrant Name
EntityRegistrantName
VERMILLION, INC.
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2018 dei Trading Symbol
TradingSymbol
vrml
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
745000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
950000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
205000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
786000
CY2017Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
867000
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
380000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
81000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-10000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
92000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
254000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13301000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-60000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9367000
CY2018Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
853000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1650000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1825000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
216000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
329000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2139000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2750000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
399400000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
414001000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7031610
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7434010
CY2017Q4 us-gaap Assets
Assets
7497000
CY2018Q4 us-gaap Assets
Assets
11408000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
6305000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
10788000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Rolling After Year Five
CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Rolling Year Five
CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Rolling Year Four
CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Rolling Year Three
CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Rolling Year Two
CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Next Rolling Twelve Months
CapitalLeasesFutureMinimumPaymentsNextRollingTwelveMonths
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5242000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5539000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9360000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
297000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3821000
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2810338
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2810338
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60036017
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
29000
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
17768000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
20614000
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
56943596
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
70085842
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75501394
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60036017
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75501394
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
60000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
75000
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Concentration of Credit Risk</font> </p> <p style="margin:0pt 0pt 6pt;text-indent:36pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents and accounts receivable.&nbsp;&nbsp;The Company maintains cash and cash equivalents in recognized financial institutions in the United States.&nbsp;&nbsp;The funds are insured by the FDIC up to a maximum of </font><font style="display: inline;">$250,000</font><font style="display: inline;">, but are otherwise unprotected.&nbsp;&nbsp;The Company has not experienced any losses associated with deposits of cash and cash equivalents.&nbsp;&nbsp;The Company does not invest in derivative instruments or engage in hedging activities.</font> </p> <p><font size="1"> </font></p> </div> </div>
CY2017 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2914000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3142000
CY2017Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
500000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
23320000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
25430000
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2461000
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2406000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
23320000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
25430000
CY2017Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
CY2018Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
CY2017Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
CY2018Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
CY2017 us-gaap Depreciation
Depreciation
786000
CY2018 us-gaap Depreciation
Depreciation
675000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
786000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
675000
CY2017 us-gaap Dilutive Securities
DilutiveSecurities
CY2018 us-gaap Dilutive Securities
DilutiveSecurities
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2018 us-gaap Finite Lived Intangible Assets Cost Incurred To Renew Or Extend
FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend
219000
CY2017 us-gaap Finite Lived Intangible Assets Cost Incurred To Renew Or Extend
FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend
258000
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.05
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.01
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.74
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.19
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-1.11
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.02
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.04
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.01
CY2018Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1540000
CY2018 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y7M24D
CY2017 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4000
CY2018 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-11000
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5543000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5052000
CY2017 us-gaap Gross Profit
GrossProfit
207000
CY2018 us-gaap Gross Profit
GrossProfit
-89000
CY2017Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2018Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-70000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-28000
CY2017 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-42000
CY2018 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-22000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
47000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
44000
CY2017Q4 us-gaap Inventory Net
InventoryNet
102000
CY2018Q4 us-gaap Inventory Net
InventoryNet
92000
CY2017Q4 us-gaap Liabilities
Liabilities
4090000
CY2018Q4 us-gaap Liabilities
Liabilities
4256000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling After Year Five
OperatingLeasesFutureMinimumPaymentsDueInRollingAfterYearFive
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Five
OperatingLeasesFutureMinimumPaymentsDueInRollingYearFive
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12000
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
29000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-16000
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
50000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7497000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11408000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2609000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2964000
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1481000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1292000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8486000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-113000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8129000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-10497000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-11371000
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11439000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11371000
CY2017 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11439000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11371000
CY2018 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2017 us-gaap Operating Expenses
OperatingExpenses
10648000
CY2018 us-gaap Operating Expenses
OperatingExpenses
11244000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-10441000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-11333000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
474000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Four
OperatingLeasesFutureMinimumPaymentsDueInRollingYearFour
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Three
OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree
56000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Two
OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo
140000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Next Rolling Twelve Months
OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths
278000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
265000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
209000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
277000
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
CY2017 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3576000
CY2017Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3576000
CY2018 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
60000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
113000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3320000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
459000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
550000
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8990000
CY2017 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
CY2018 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
4496000
CY2017 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
5127000
CY2018 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
CY2018Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
13500000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3358000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1181000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
608000
CY2017 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
34000
CY2018 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
29000
CY2017 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
183000
CY2018 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
185000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
837000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
550000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-396053000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-406924000
CY2017 us-gaap Revenues
Revenues
3121000
CY2018 us-gaap Revenues
Revenues
3053000
CY2017 us-gaap Royalty Expense
RoyaltyExpense
116000
CY2018 us-gaap Royalty Expense
RoyaltyExpense
120000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.69
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0177
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0269
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
4000000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2989760
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2054633
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5178819
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2391760
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.94
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y8M19D
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
9000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
3050
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
879063
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1548000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1304000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.11
CY2017 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4268000
CY2018 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5642000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
1439000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
1101000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
163582
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
432877
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.69
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
18000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
779505
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
879063
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.51
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.58
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
779505
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.51
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
41000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1033000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3451073
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4219568
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4612005
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.70
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.86
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.67
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y5M16D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y7D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M1D
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1820601
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.39
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P8Y8M27D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2272000
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2319000
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.89
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.05
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.98
CY2018Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
1.94
CY2018 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
0.01
CY2018Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
2391760
CY2018Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
4612005
CY2018Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
1.67
CY2018 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y2M1D
CY2018 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
11.55
CY2017Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
185000
CY2018Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
189000
CY2017 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
1104000
CY2018 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
663000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
3762000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
3407000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
7152000
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
32500
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8990000
CY2017 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
335000
CY2018 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
438000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
29000
CY2018Q4 vrml Deferred Tax Assets Intangible Assets Amortization
DeferredTaxAssetsIntangibleAssetsAmortization
2410000
CY2017 vrml Effective Income Tax Rate Reconciliation Permanent Items
EffectiveIncomeTaxRateReconciliationPermanentItems
-0.02
CY2018 vrml Effective Income Tax Rate Reconciliation Permanent Items
EffectiveIncomeTaxRateReconciliationPermanentItems
CY2017Q4 vrml Deferred Tax Assets Intangible Assets Amortization
DeferredTaxAssetsIntangibleAssetsAmortization
3091000
CY2017 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
942000
CY2018 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10747000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10828000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10967000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
81000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
34000
CY2017 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
CY2018 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
CY2018Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
10967000
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Use of Estimates</font> </p> <p style="margin:0pt 0pt 6pt;text-indent:36pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The preparation of consolidated financial statements in accordance with generally accepted accounting principles in the U.S. (&#x201C;GAAP&#x201D;) requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes.&nbsp;&nbsp;The primary estimates underlying the Company&#x2019;s consolidated financial statements include assumptions regarding revenue recognition as well as variables used in calculating the fair value of the Company&#x2019;s equity awards, income taxes and contingent liabilities.&nbsp;&nbsp;Actual results could differ from those estimates.</font> </p> <p><font size="1"> </font></p> </div> </div>
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2000000
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56943596
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70085842
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56943596
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70085842
CY2017Q4 vrml Collaboration And Research Agreement Costs
CollaborationAndResearchAgreementCosts
358000
CY2018Q4 vrml Collaboration And Research Agreement Costs
CollaborationAndResearchAgreementCosts
366000
CY2017 vrml Common Stock And Warrants Issued In Conjunction With Private Placement Sale Net Of Issuance Costs
CommonStockAndWarrantsIssuedInConjunctionWithPrivatePlacementSaleNetOfIssuanceCosts
5127000
CY2018Q4 vrml Contractual Obligations Future Minimum Payments Due
ContractualObligationsFutureMinimumPaymentsDue
2095000
CY2018Q4 vrml Contractual Obligations Future Minimum Payments Due Current
ContractualObligationsFutureMinimumPaymentsDueCurrent
499000
CY2018Q4 vrml Contractual Obligations Future Minimum Payments Due In Five Years
ContractualObligationsFutureMinimumPaymentsDueInFiveYears
221000
CY2018Q4 vrml Contractual Obligations Future Minimum Payments Due In Four Years
ContractualObligationsFutureMinimumPaymentsDueInFourYears
221000
CY2018Q4 vrml Contractual Obligations Future Minimum Payments Due In Three Years
ContractualObligationsFutureMinimumPaymentsDueInThreeYears
277000
CY2018Q4 vrml Contractual Obligations Future Minimum Payments Due In Two Years
ContractualObligationsFutureMinimumPaymentsDueInTwoYears
361000
CY2018Q4 vrml Contractual Obligations Future Minimum Payments Due Thereafter
ContractualObligationsFutureMinimumPaymentsDueThereafter
516000
CY2018Q4 vrml Debt Obligations Future Minimum Payments Due
DebtObligationsFutureMinimumPaymentsDue
1621000
CY2018Q4 vrml Debt Obligations Future Minimum Payments Due Current
DebtObligationsFutureMinimumPaymentsDueCurrent
221000
CY2018Q4 vrml Debt Obligations Future Minimum Payments Due In Five Years
DebtObligationsFutureMinimumPaymentsDueInFiveYears
221000
CY2018Q4 vrml Debt Obligations Future Minimum Payments Due In Four Years
DebtObligationsFutureMinimumPaymentsDueInFourYears
221000
CY2018Q4 vrml Debt Obligations Future Minimum Payments Due In Three Years
DebtObligationsFutureMinimumPaymentsDueInThreeYears
221000
CY2018Q4 vrml Debt Obligations Future Minimum Payments Due In Two Years
DebtObligationsFutureMinimumPaymentsDueInTwoYears
221000
CY2018Q4 vrml Debt Obligations Future Minimum Payments Due Thereafter
DebtObligationsFutureMinimumPaymentsDueThereafter
516000
CY2017 vrml Deemed Dividend On Warrant Repricing
DeemedDividendOnWarrantRepricing
942000
CY2018 vrml Deemed Dividend On Warrant Repricing
DeemedDividendOnWarrantRepricing
CY2018 vrml Number Of Operating Office Leases
NumberOfOperatingOfficeLeases
2
CY2018Q2 vrml Number Of Public Offerings
NumberOfPublicOfferings
2
CY2018 vrml Preferred Stock Value New Issues In Conjunction With Public Offering Net Of Issuance Costs
PreferredStockValueNewIssuesInConjunctionWithPublicOfferingNetOfIssuanceCosts
4496000
CY2017 vrml Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
3576000
CY2018 vrml Unrecognized Tax Benefits Return To Provision True Up
UnrecognizedTaxBenefitsReturnToProvisionTrueUp
105000

Files In Submission

Name View Source Status
0000926617-19-000007-index-headers.html Edgar Link pending
0000926617-19-000007-index.html Edgar Link pending
0000926617-19-000007.txt Edgar Link pending
0000926617-19-000007-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrml-20181231.xml Edgar Link completed
vrml-20181231.xsd Edgar Link pending
vrml-20181231x10k.htm Edgar Link pending
vrml-20181231xex10_7.htm Edgar Link pending
vrml-20181231xex10_8.htm Edgar Link pending
vrml-20181231xex21_0.htm Edgar Link pending
vrml-20181231xex23_1.htm Edgar Link pending
vrml-20181231xex31_1.htm Edgar Link pending
vrml-20181231xex31_2.htm Edgar Link pending
vrml-20181231xex32_0.htm Edgar Link pending
vrml-20181231_cal.xml Edgar Link unprocessable
vrml-20181231_def.xml Edgar Link unprocessable
vrml-20181231_lab.xml Edgar Link unprocessable
vrml-20181231_pre.xml Edgar Link unprocessable